CD99 and acute lymphoblastic leukemia: Preclinical studies reported that anti-CD99 mAbs induced caspase-independent cell death of AML cell lines and primary blasts [175], T-cell lines [176], and TEL/AML1-positive ALL and normal B-cell precursors [177].